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ABSTRACT. A series of novel [1,2,4]triazolo[4,3-c][1,3,5,2]triazaphosphinine-5-oxidederivatives 2a-h were 
synthesized by a reaction of N-alkyl/aryl-N'-(4H-1,2,4-triazol-3-yl) amidines with N,N-dimethylphosphoramic 
dichloride in the presence of triethylamine (TEA) in refluxing 1,4-dioxane. The structures of all the synthesized 
compounds have been established by NMR (1H, 13C, 31P) and IR spectroscopy, as well as by elemental analysis 
and mass spectral analysis. 
  




The rich chemistry and wide applications of organophosphorus compounds are receiving 
tremendous attraction by scientists [1-3]. Organophosphorus compounds, which are a wide class 
of chemical compounds containing organic moieties disciplines usually bonded directly to 
phosphorus or bonded through a heteroatom, such as sulfur, oxygen or nitrogen, are one of the 
most common chemicals in the human environment. Because of their unique properties and high 
biological activity, they have been demonstrated to possess anticancer [4], antimicrobial [5] and 
insecticidal activities [6].  
On the other hand, it is known that [1,2,4]-triazole containingheterocyclic compounds are  
very interesting biologically active: antifungal [7], antibacterial [7], herbicidal [8], anticancer [9] 
and antileishmainal [10] effects. These observations encouraged us to synthesize of novel 
triazaphosphinine oxides containing[1,2,4]-triazole ring such as [1,2,4]triazolo[4,3-
c][1,3,5,2]triazaphosphinine-5-oxidesderivatives. 
 
RESULTS AND DISCUSION 
 
N-alkyl/aryl-N'-(4H-1,2,4-triazol-3-yl) amidines 1, which are the starting material for this work, 
were obtained from the reaction of N-triazol-3-yl imidates with primary amines at room 
temperature in absolute ethanol [11]. The reaction between amidines 1 with N,N'-
dimethylphosphoramicdichloride in the presence of triethylamine (TEA) under reflux of dioxane 
leads to [1,2,4]triazolo[4,3-c][1,3,5,2]triazaphosphinine-5-oxides derivatives 2a-h (Scheme 1, 
Table 1). 
The structures of compounds 2a-h were deduced from their IR, 1H NMR, 13C NMR, MS 
spectra and elemental analysis. The IR spectra of compounds 2a-h display absorption bands in 
the region of 1615-1612 cm-1 (C=N), 1300-1298 cm-1 (P=O) and strong bands in the region of 
1190-1170 cm-1 indicating the presence of P-N moeity. 
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The 1H NMR spectra data of products 2a-h revealed the total absence of a signal specific to 
the NH amidinic and NH triazolic protons and they show the presence of separate signals for the 
two methyl groups in N(CH3)2 groups introduced by N,N-dimethylphosphoramicdichloride, 
which are splitted into doublets due to coupling with phosphorus. 
13C NMR spectra of compounds 2a-h exhibited two signals attributable to the carbon atoms 
of P-NMe, indicating that the two methyl groups are not equivalent. The 31P NMR spectrum of 




Scheme 1. Synthesis reaction of [1,2,4]triazolo[4,3-c][1,3,5,2]triazaphosphinine-5-oxides 2a-h. 
 
 R1 R2 
2a Methyl Ethyl 
2b Ethyl Ethyl 
2c Methyl Propyl 
2d Ethyl Propyl 
2e Methyl Cyclopentyl 
2f Ethyl Cyclopentyl 
2g Methyl Phenyl-CH2 
2h Ethyl Phenyl-CH2 
 
Table 1. The results of synthesis of [1,2,4]triazolo[4,3-c][1,3,5,2]triazaphosphinine-5-oxides derivatives 
(2a-h). 
 
Entry Products R1 R2 Yields (%) M.p. (°C) 
1 2a Methyl Ethyl 70 180-182 
2 2b Ethyl Ethyl 68 194-196 
3 2c Methyl Propyl 52 - 
4 2d Ethyl Propyl 60 - 
5 2e Methyl Cyclopentyl 65 212-214 
6 2f Ethyl Cyclopentyl 72 220-222 
7 2g Methyl Phenyl-CH2 87 250-252 




In summary, the synthesis of phosphorus containing fused and isolated heterocyclic systems 
such as [1,2,4]triazolo[4,3-c][1,3,5,2]triazaphosphinine-5-oxides have been achived via reaction 
of N-alkyl/aryl-N'-(4H-1,2,4-triazol-3-yl) amidines with N,N-dimethylphosphoramicdichloride 
under reflux. 
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IR spectra were recorded with a Fourier transform infrared spectrometer (Nicolet IR 200 FT-IR, 
USA). 1H and 13C NMR spectra were recorded with (CD3)2SO solvent containing 
tetramethylsilane (TMS) on a Bruker 300 spectrometer (USA) (1H: 300 MHz, 13C: 75.47 MHz, 
31P: 121.49 MHz). The chemical shifts were reported in δ values relative to TMS (internal 
reference) for 1H and 13C and relative to 85% H3PO4 (external reference) for 
31P. For the 1H 
NMR, the multiplicities of signals are indicated by the following abbreviations: s: singlet, d: 
doublet, t: triplet, q: quartet, m: multiplet. Melting point (mp) was determined on an 
Electrothermal 9100 melting point apparatus (Weiss-Gallenkamp, Loughborough, UK). 
Elemental microanalysis was performed on a Perkin-Elmer analyzer apparatus (model 2400, 
series II-CHN, USA). The electron spray ionization (ESI) positive MS spectra were recorded on 
a Bruker Daltonics LC-MS spectrometer (USA). All chemicals, reagents and solvents were 
obtained from Sigma-Aldrich Company and were used without any purification. The completion 
of reaction was monitored by TLC. 
 
Synthesis of [1,2,4]triazolo[4,3-c][1,3,5,2]triazaphosphinine-5-oxides derivatives 2a-h  
 
N,N'-dimethylphosphoramic dichloride (2 mmol) was added dropwise to a mixture of N-
alkyl/aryl-N'-(4H-1,2,4-triazol-3-yl) amidines 1 (2 mmol) and 6 mmol of TEA in anhydrous 1,4-
dioxane (30 mL). The reaction mixture was heated under reflux for 24 h and then left to cool. 
The triethylammonium chloride obtained was filtered off. The solvent was removed under 
vacuum, and the resulting solid was collected and recrystallized from dichloromethane (2a, 2b, 
2e, 2f, 2g and 2h) or alternatively the oil obtained (2c and 2d) was purified by column 
chromatography using silica gel (60–120 mesh) with ethyl acetate:hexane (3:7) as an eluent. 
 
5-(Dimethylamino)-6-ethyl-7-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-c][1,3,5,2]triazaphos- 
phinine-5-oxide (2a). Brown powder; 1H NMR (300 MHz, DMSO-d6): δ 8.82 (s, 1H, N=CH-N-
PO), 3.28 (q, 2H, 3J = 7.8 Hz, CH3-CH2-N), 2.73 (d, 3H, O=P-N(CH3)2), 2.71 (d, 3H, O=P-
N(CH3)2), 2.18 (s, 3H, CH3-C(N)=N),1.42 (t, 3H, 
3J = 7.8 Hz, CH3-CH2-N); 
13C NMR (75.47 
MHz, DMSO-d6): δ 161.2 (N=C(CH3)-N), 155.2 (N=C(N)-N), 151.4 (N=CH-N-PO), 37.2 (d, 
2JPC = 3.5 Hz, N-CH3), 37.1 (d, 
2JPC = 3.5 Hz, N-CH3), 32.3 (d, 
2JPC = 3.2 Hz, CH3-CH2-N), 18.2 
(CH3-C(N)=N), 12.2 (CH3-CH2-N); 
31P NMR (121.49 MHz, DMSO-d6): δ 26.1; IR, ν (cm
-1): 
1190 (P-N), 1298 (P=O), 1612 (C=N); ESI-MS [M+1]+: m/z = 243. Anal. calcd. for C8H15N6OP 
(%): C, 39.67; H, 6.24; N, 34.70. Found: C, 39.65; H, 6.22; N, 34.69.  
 
5-(Dimethylamino)-6,7-diethyl-5,6-dihydro-[1,2,4]triazolo[4,3-c][1,3,5,2]triazaphosphinine-5-
oxide (2b). Brown powder; 1H NMR (300 MHz, DMSO-d6): δ 8.80 (s, 1H, N=CH-N-PO), 3.26 
(q, 2H, 3J = 7.8 Hz, CH3-CH2-N), 2.74 (d, 3H, O=P-N(CH3)2), 2.73 (d, 3H, O=P-N(CH3)2), 2.28 
(q, 2H, 3J = 8.6 Hz, CH3-CH2-C(N)=N), 1.22 (t, 3H, 
3J = 8.6 Hz, CH3-CH2-C(N)=N); 
13C NMR 
(75.47 MHz, DMSO-d6): δ 163.2 (N=C(CH2-CH3)-N), 155.8 (N=C(N)-N), 148.4 (N=CH-N-
PO), 37.2 (d, 2JPC = 3.5 Hz, N-CH3), 37.1 (d, 
2JPC = 3.5 Hz, N-CH3), 32.5 (d, 
2JPC = 3.2 Hz, CH3-
CH2-N), 23.2 (CH3-CH2-C(N)=N), 13.3 (CH3-CH2-N), 10.9 (CH3-CH2-C(N)=N). 
31P NMR 
(121.49 MHz, DMSO-d6): δ 26.3; IR, ν (cm
-1): 1186 (P-N), 1298 (P=O), 1612 (C=N); ESI-MS 
[M+1]+: m/z = 257. Anal. calcd. for C9H17N6OP (%): C, 42.18; H, 6.69; N, 32.80. Found: C, 
42.17; H, 6.67; N, 32.78. 
 
5-(Dimethylamino)-7-methyl-6-propyl-5,6-dihydro-[1,2,4]triazolo[4,3-c][1,3,5,2]triazaphos- 
phinine-5-oxide (2c). Light brown viscous oil; 1H NMR (300 MHz, DMSO-d6): δ 8.86 (s, 1H, 
N=CH-N-PO), 3.24 (t, 2H, 3J = 7.6 Hz, CH3-CH2-CH2-N), 2.71 (d, 3H, O=P-N(CH3)2), 2.69 (d, 
3H, O=P-N(CH3)2), 2.20 (s, 3H, CH3-C(N)=N), 1.38 (m, 2H, CH3-CH2-CH2-N), 0.99 (t, 3H, 
3J = 
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7.6 Hz, CH3-CH2-CH2-N); 
13C-NMR (75.47 MHz, DMSO-d6) δ (ppm): 160.8 (N=C(CH3)-N), 
154.8 (N=C(N)-N), 141.9 (N=CH-N-PO), 46.1 (d, 2JPC = 3.2 Hz, CH3-CH2-CH2-N), 37.2 (d, 
2JPC 
= 3.5 Hz, N-CH3), 37.1 (d, 
2JPC = 3.5 Hz, N-CH3),21.1 (N=C(CH3)-N), 20.8 (CH3-CH2-CH2-N), 
12.7 (CH3-CH2-CH2-N).
 31P NMR (121.49 MHz, DMSO-d6): δ 26.1; IR, ν (cm
-1): 1188 (P-N), 
1298 (P=O), 1613 (C=N); ESI-MS [M+1]+: m/z = 257. Anal. calcd. for C9H17N6OP (%): C, 
42.18; H, 6.69; N, 32.80. Found: C, 42.16; H, 6.66; N, 32.78. 
 
5-(Dimethylamino)-7-ethyl-6-propyl-5,6-dihydro-[1,2,4]triazolo[4,3-c][1,3,5,2]triazaphos- 
phinine-5-oxide(2d). Brown viscous oil; 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 8.86 (s, 1H, 
N=CH-N-PO), 3.23 (t, 2H, 3JH-H = 7.6 Hz, CH3-CH2-CH2-N), 2.71 (d, 3H, O=P-N(CH3)2), 2.69 
(d, 3H, O=P-N(CH3)2), 1.48 (m, 2H, CH3-CH2-CH2-N), 1.39 (q, 2H, 
3JH-H = 8.6 Hz, CH3-CH2-
C(N)=N), 1.20  (t, 3H, 3JH-H = 8.6 Hz, CH3-CH2-C(N)=N), 1.01 (t, 3H, 
3JH-H = 7.6 Hz, CH3-CH2-
CH2-N);
 13C-NMR (75.47MHz, DMSO-d6) δ (ppm): 161.2 (N=C(CH2-CH3)-N), 155.6 
(N=C(N)-N), 143.3 (N=CH-N-PO), 44.8 (d, 2JPC = 3.1 CH3-CH2-CH2-N),37.2 (d, 
2JPC = 3.5 Hz, 
N-CH3), 37.1 (d, 
2JPC = 3.5 Hz, N-CH3), 21.4 (CH3-CH2-CH2-N), 12.3 (CH3-CH2-CH2-N), 11.8 
(N=C(CH2-CH3)-N). 
31P NMR (121.49 MHz, DMSO-d6): δ 26.4. IR, ν (cm
-1): 1170 (P-N), 1298 
(P=O), 1612 (C=N); ESI-MS [M+1]+: m/z = 271. Anal. calcd. for C10H19N6OP (%): C, 44.44; H, 
7.09; N, 31.09. Found: C, 44.42; H, 7.07; N, 31.05. 
 
6-Cyclopentyl-5-(dimethylamino)-7-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-c][1,3,5,2]triaza- 
phosphinine 5-oxide (2e). Dark brown powder; 1H-NMR (300 MHz, DMSO-d6): δ 8.84 (s, 1H, 
N=CH-N-PO), 3.78 (m, 1H, CH2-CH2-CH2-CH2-CH-N), 2.71 (d, 3H, O=P-N(CH3)2), 2.69 (d, 
3H, O=P-N(CH3)2), 2.22 (s, 1H, CH3-C(N)=N), 1.74 (m, 4H, CH2-CH2-CH2-CH2-CH-N), 1.41 
(m, 4H, CH2-CH2-CH2-CH2-CH-N); 
13C-NMR (75.47 MHz, DMSO-d6) δ (ppm): 160.6 
(N=C(CH3)-N), 155.7 (N=C(N)-N), 143.8 (N=CH-N-PO), 53.1 (d, 
2JPC = 3.2 Hz, CH2-CH2-
CH2-CH2-CH-N), 37.4 (d, 
2JPC = 3.5 Hz, N-CH3), 37.3 (d, 
2JPC = 3.5 Hz, N-CH3), 34.2 (CH2-
CH2-CH2-CH2-CH-N), 22.5 (CH2-CH2-CH2-CH2-CH-N), 21.3 (N=C(CH3)-N); 
31P NMR 
(121.49 MHz, DMSO-d6): δ 26.6. IR, ν (cm
-1): 1175 (P-N), 1298 (P=O), 1612 (C=N); ESI-MS 
[M+1]+: m/z = 283. Anal. calcd. for C11H19N6OP (%): C, 46.80; H, 6.78; N, 29.77; Found: C, 
46.78; H, 6.79; N, 29.75. 
 
6-Cyclopentyl-5-(dimethylamino)-7-ethyl-5,6-dihydro-[1,2,4]triazolo[4,3-c][1,3,5,2]triaza- 
phosphinine-5-oxide (2f). Dark brown powder; 1H-NMR (300 MHz, DMSO-d6)) δ (ppm): 8.89 
(s, 1H, N=CH-N-PO), 3.80 (m, 1H, CH2-CH2-CH2-CH2-CH-N), 2.28 (q, 2H, 
3JH-H = 8.2 Hz, 
CH3-CH2-C(N)=N), ), 2.71 (d, 3H, O=P-N(CH3)2), 2.69 (d, 3H, O=P-N(CH3)2), 1.71 (m, 4H, 
CH2-CH2-CH2-CH2-CH N), 1.46 (m, 4H, CH2-CH2-CH2-CH2-CH-N), 1.24 (t, 3H, 
3JH-H  = 8.2 
Hz, CH3-CH2-C(N)=N); 
13C-NMR (75.47 MHz, DMSO-d6) δ (ppm): 162.1 (N=C(CH2-CH3)-N), 
154.8 (N=C(N)-N), 143.5 (N=CH-N-PO), 53.7 (d, 2JPC = 3.1 Hz, CH2-CH2-CH2-CH2-CH-N), 
37.4 (d, 2JPC = 3.5 Hz, N-CH3), 37.2 (d, 
2JPC = 3.5 Hz, N-CH3), 33.6 (CH2-CH2-CH2-CH2-CH-
N), 25.1 (N=C(CH2-CH3)-N), 22.1 (CH2-CH2-CH2-CH2-CH-N), 11.8(N=C(CH2-CH3)-N). 
31P 
NMR (121.49 MHz, DMSO-d6): δ 26.4. IR, ν (cm
-1): 1175 (P-N), 1298 (P=O), 1612 (C=N); 
ESI-MS [M+1]+: m/z = 297. Anal. calcd. for C12H21N6OP (%): C, 48.64; H, 7.14; N, 28.36; 
Found: C, 48.62; H, 7.11; N, 28.34. 
 
6-Benzyl-5-(dimethylamino)-7-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-c][1,3,5,2]triazaphos- 
phinine-5-oxide (2g). Colorless crystals; 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 8.85 (s, 1H, 
N=CH-N-PO), 7.32-7.70 (m, 5H, Ar), 3.84 (s, 2H, C6H5-CH2-N), 2.71 (d, 3H, O=P-N(CH3)2), 
2.69 (d, 3H, O=P-N(CH3)2), 2.17 (s, 3H, CH3-C(N)=N); 
13C-NMR (75.47 MHz, DMSO-d6) δ 
(ppm): 162.3 (N=C(CH3)-N), 154.6 (N=C(N)-N), 143.8 (N=CH-N-PO), 137.8 (1Carom, C6H5-
CH2-N), 128.6 (2Carom, C6H5-CH(N)-N), 127.1 (2Carom, C6H5), 126.6 (1Carom, C6H5), 37.4 (d, 
2JPC 
= 3.5 Hz, N-CH3), 37.2 (d, 
2JPC = 3.5 Hz, N-CH3), 44.6 (d, 
2JPC = 3.1 Hz, C6H5-CH2-N), 23.2 
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(N=C(CH3)-N); ).
31P NMR (121.49 MHz, DMSO-d6): δ 26.2. IR, ν (cm
-1): 1186 (P-N), 1300 
(P=O), 1615(C=N); ESI-MS [M+1]+: m/z = 305. Anal. calcd. for C13H17N6OP (%): C, 51.31; H, 
5.63; N, 27.62; Found: C, 51.27; H, 5.60; N, 27.59. 
 
6-Benzyl-5-(dimethylamino)-7-ethyl-5,6-dihydro-[1,2,4]triazolo[4,3-c][1,3,5,2]triazaphos- 
phinine-5-oxide (2h). Colorless crystals; 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 8.86 (s, 1H, 
N=CH-N), 7.38-7.78 (m, 5H, Ar),  3.86 (s, 2H, C6H5-CH2-N), 2.71 (d, 3H, O=P-N(CH3)2), 2.69 
(d, 3H, O=P-N(CH3)2), 1.42 (q, 2H, 
3JH-H = 8.6 Hz, 1H, CH3-CH2-C(N)=N), 1.24 (t, 3H, 
3JH-H = 
8.6 Hz, 1H, CH3-CH2-C(N)=N); 
13C-NMR (75.47 MHz, DMSO-d6) δ (ppm): 162.5 (N=C(CH2-
CH3)-N), 156.1 (N=C(N)-N), 143.7 (N=CH-N-PO), 136.8 (1Carom, C6H5-CH2-N), 129.1 (2Carom, 
C6H5), 128.6 (2Carom, C6H5), 126.2 (1Carom, C6H5), 37.4 (d, 
2JPC = 3.5 Hz, N-CH3), 37.2 (d, 
2JPC = 
3.5 Hz, N-CH3), 45.4 (d, 
2JPC = 3.1 Hz, C6H5-CH2-N), 23.5 (N=C(CH2-CH3)-N), 11.9 
(N=C(CH2-CH3)-N); 
31P NMR (121.49 MHz, DMSO-d6): δ 26.3. IR, ν (cm
-1): 1186 (P-N), 1300 
(P=O), 1615(C=N); ESI-MS [M+1]+: m/z = 319. Anal. calcd. for C14H19N6OP (%): C, 52.83; H, 
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